EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Hyperlipidemic Effect of Fucoidan Fractions Prepared from Iceland Brown Algae Ascophyllum nodosum in an Hyperlipidemic Mice Model

Yunhai He, Yutong Li, Peili Shen, Shangkun Li, Linsong Zhang, Qiukuan Wang, Dandan Ren, Shu Liu, Demeng Zhang, Hui Zhou

Marine Drugs · 2023

DOI: 10.3390/md21090468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Yunhai He und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Engineering, Dalian Ocean University, Dalian 116023, China. Hauptthemen laut MEDLINE: Polysaccharides, Hyperlipidemias, Ascophyllum, Hypolipidemic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, China Agriculture Research System, General Scientific Project from Department of Education of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ascophyllum nodosum, a brown algae abundantly found along the North Atlantic coast, is recognized for its high polysaccharide content. In this study, we investigated the anti-hyperlipidemic effect of fucoidans derived from A. nodosum, aiming to provide information for their potential application in anti-hyperlipidemic therapies and to explore comprehensive utilization of this Iceland brown seaweed. The crude fucoidan prepared from A. nodosum was separated using a diethylethanolamine column, resulting in two fucoidan fractions, AFC-1 and AFC-2. Both fractions were predominantly composed of fucose and xylose. AFC-1 exhibited a higher sulfate content of 27.8% compared to AFC-2 with 17.0%. AFC-2 was primarily sulfated at the hydroxy group of C2, whereas AFC-1 was sulfated at both the hydroxy groups of C2 and C4. To evaluate the anti-hyperlipidemic effect, a hyperlipidemia mouse model was established by feeding mice a high-fat diet. The effects of AFC-1, AFC-2, and the crude extract were investigated, with the drug atorvastatin used as a positive comparison. Among the different fucoidan fractions and doses, the high dose of AFC-2 administration demonstrated the most significant anti-hyperlipidemic effect across various aspects, including physiological parameters, blood glucose levels, lipid profile, histological analysis, and the activities of oxidative stress-related enzymes and lipoprotein-metabolism-related enzymes (p < 0.05 for the final body weight and p < 0.01 for the rest indicators, compared with the model group), and its effect is comparable to the atorvastatin administration. Furthermore, fucoidan administration resulted in a lower degree of loss in gut flora diversity compared to atorvastatin administration. These findings highlight the significant biomedical potential of fucoidans derived from A. nodosum as a promising therapeutic solution for hypolipidemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesHyperlipidemiasAscophyllumHypolipidemic AgentsAnimalsMiceDisease Models, AnimalMaleDiet, High-FatIcelandPhaeophyceaeAtorvastatinSeaweed

Stichwörter der Autor:innen

Ascophyllum nodosumanti-hyperlipidemicantioxidant enzymefucoidangut floralipoprotein metabolism

Substanzen

PolysaccharidesfucoidanHypolipidemic AgentsAtorvastatin

Autor:innen und Institutionen

  • College of Food Science and Engineering, Dalian Ocean University, Dalian 116023, China.
  • State Key Laboratory of Marine Food Processing & Safety Control, Qingdao Bright Moon Seaweed Group Co., Ltd., Qingdao 266400, China.
  • Key Laboratory of Aquatic Product Processing and Utilization of Liaoning Province, Dalian Ocean University, Dalian 116023, China.
  • National R&D Branch Center for Seaweed Processing, Dalian Ocean University, Dalian 116023, China.

Förderung

  • National Key R&amp;D Program of China
  • China Agriculture Research System
  • General Scientific Project from Department of Education of Liaoning Province
  • Open Foundation of the State Key Laboratory of Bioactive Seaweed Substances

Zitieren

APA

He, Y., Li, Y., Shen, P., Li, S., Zhang, L., Wang, Q., Ren, D., Liu, S., Zhang, D., & Zhou, H. (2023). Anti-Hyperlipidemic Effect of Fucoidan Fractions Prepared from Iceland Brown Algae Ascophyllum nodosum in an Hyperlipidemic Mice Model. Marine Drugs. https://doi.org/10.3390/md21090468

Vancouver

He Y, Li Y, Shen P, Li S, Zhang L, Wang Q, et al. Anti-Hyperlipidemic Effect of Fucoidan Fractions Prepared from Iceland Brown Algae Ascophyllum nodosum in an Hyperlipidemic Mice Model. Marine Drugs. 2023. doi:10.3390/md21090468

BibTeX
@article{He2023,
  author = {He, Yunhai and Li, Yutong and Shen, Peili and Li, Shangkun and Zhang, Linsong and Wang, Qiukuan and Ren, Dandan and Liu, Shu and Zhang, Demeng and Zhou, Hui},
  title = {Anti-Hyperlipidemic Effect of Fucoidan Fractions Prepared from Iceland Brown Algae Ascophyllum nodosum in an Hyperlipidemic Mice Model},
  journal = {Marine Drugs},
  year = {2023},
  doi = {10.3390/md21090468}
}
Kostenlos starten →